Outsourced Pharma Capabilities Update May 2026: Large Molecule

Watch Leading CDMOs share their current capabilities, facility locations, and timelines – to help you identify options for your development and manufacturing needs.

Dive into the biopharmaceutical realm, where the synthesis of biologically derived APIs encompasses cell line development, fermentation, and sophisticated purification techniques. The event will feature insights into process optimization and scale-up, which are crucial for meeting production demands without compromising quality. Discover the meticulous quality control practices that underpin the production of biopharmaceuticals, laying the groundwork for novel biologic therapies.

What can you expect? – Short, digital presentations to give you an inside look at the current capabilities of industry suppliers. You will have the opportunity to submit questions of each CDMO to better understand if they can meet your needs – all from the convenience of your computer!